APA (7th ed.) Citation

Kozar, N., & Lovrec, V. G. (2024). Ki67 can be used as a predictive factor for the effectiveness of neoadjuvant chemotherapy in breast cancer patients. European Journal of Gynaecological Oncology, 45(6), 150. https://doi.org/10.22514/ejgo.2024.128

Chicago Style (17th ed.) Citation

Kozar, Nejc, and Vida Gavrić Lovrec. "Ki67 Can Be Used as a Predictive Factor for the Effectiveness of Neoadjuvant Chemotherapy in Breast Cancer Patients." European Journal of Gynaecological Oncology 45, no. 6 (2024): 150. https://doi.org/10.22514/ejgo.2024.128.

MLA (9th ed.) Citation

Kozar, Nejc, and Vida Gavrić Lovrec. "Ki67 Can Be Used as a Predictive Factor for the Effectiveness of Neoadjuvant Chemotherapy in Breast Cancer Patients." European Journal of Gynaecological Oncology, vol. 45, no. 6, 2024, p. 150, https://doi.org/10.22514/ejgo.2024.128.